- Home
- MHK vs CORT Comparison
MHK vs CORT Comparison
Compare MHK & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHK
- CORT
- Stock Information
- Founded
- MHK 1988
- CORT 1998
- Country
- MHK United States
- CORT United States
- Employees
- MHK N/A
- CORT N/A
- Industry
- MHK Home Furnishings
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- MHK Consumer Discretionary
- CORT Health Care
- Exchange
- MHK Nasdaq
- CORT Nasdaq
- Market Cap
- MHK 6.3B
- CORT 7.5B
- IPO Year
- MHK 1992
- CORT N/A
- Fundamental
- Price
- MHK $109.72
- CORT $69.31
- Analyst Decision
- MHK Buy
- CORT Strong Buy
- Analyst Count
- MHK 14
- CORT 4
- Target Price
- MHK $141.64
- CORT $142.00
- AVG Volume (30 Days)
- MHK 821.7K
- CORT 1.6M
- Earning Date
- MHK 07-24-2025
- CORT 07-28-2025
- Dividend Yield
- MHK N/A
- CORT N/A
- EPS Growth
- MHK N/A
- CORT 8.36
- EPS
- MHK 7.66
- CORT 1.14
- Revenue
- MHK $10,683,300,000.00
- CORT $685,446,000.00
- Revenue This Year
- MHK N/A
- CORT $35.83
- Revenue Next Year
- MHK $3.03
- CORT $35.24
- P/E Ratio
- MHK $14.28
- CORT $60.73
- Revenue Growth
- MHK N/A
- CORT 30.93
- 52 Week Low
- MHK $96.24
- CORT $29.42
- 52 Week High
- MHK $164.29
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- MHK 55.77
- CORT 41.95
- Support Level
- MHK $103.48
- CORT $72.48
- Resistance Level
- MHK $105.59
- CORT $75.95
- Average True Range (ATR)
- MHK 2.67
- CORT 2.69
- MACD
- MHK 0.59
- CORT -0.10
- Stochastic Oscillator
- MHK 84.63
- CORT 0.37
About MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.